Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference
(Thomson Reuters ONE) -
GAITHERSBURG, Md., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the
discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO,
will present at the 26(th) Annual Piper Jaffray Healthcare Conference on
Wednesday, December 3, 2014 at 11:00 a.m. ET in New York, NY at The New York
Palace Hotel.
A live webcast link for the presentation will be available via the company''s
website at www.novavax.com under Investor Info/Events.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating vaccines and vaccine adjuvants to address a broad range of infectious
diseases worldwide. Using innovative proprietary recombinant nanoparticle
vaccine technology, the company produces vaccine candidates to efficiently and
effectively respond to both known and newly emergent diseases.
CONTACT: Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1874373]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.11.2014 - 08:33 Uhr
Sprache: Deutsch
News-ID 1321399
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Maryland
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
